IL1B and breast carcinoma: Interestingly, estrogenic GPER1 activation is able to regulate the expression of the pro-inflammatory cytokine IL1β and its receptor IL1R1 in CAFs and breast cancer cells, respectively, suggesting a fine feedforward, which links tumor microenvironment with tumor cells toward the progression of breast cancer [73].